This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 23 Feb 2021  |  North America  |  Mega Trends

    AI-Based Image Analysis Tools and Cloud-Based Deployment to Expand the Global Digital Pathology Market

    Increased Demand for Remote Pathology Services and Centralization of Digital Pathology Workflow in Hospital Networks to Spark New Growth Opportunities

    The Transformational Health team at Frost & Sullivan provides critical insights into the global digital pathology market, highlighting key growth opportunities, market revenue forecast, and business models that will play an essential role in its growth. The study segments the market by product (hardware, software, and storage solutions) and region ...

    $4,950.00
  2. 19 Feb 2021  |  North America  |  Mega Trends

    Regulatory and Infrastructure Reforms in India and China Catalyzing the Asian Specialty Generics Market

    High Unmet Needs in Niche Oncology Indications will Drive Future Growth Potential

    Frost & Sullivans Transformational Health team provides critical insights into the Asian specialty generics market with this research service, highlighting growth opportunities, selected countries biopharmaceutical environment, and significant R&D, regulatory, and infrastructure reforms influencing its growth. The report examines similarities and c...

    $2,450.00
  3. 16 Feb 2021  |  North America  |  Mega Trends

    Smartphone-based Saliva Testing and Self-monitoring of Blood Glucose Driving the Digital POCT Market

    Mobility Ecosystem Holds Bold Promise to Expand Patients’ Access to Care

    Smartphone-based devices and associated tools are becoming the ideal next-generation point-of-care testing (POCT) solutions for in vitro diagnostics. The global COVID-19 pandemic has led to frugal innovations in POCT. The World Health Organization (WHO) has endorsed POCT as the topmost research priority in response to the COVID-19 outbreak. Digital...

    $2,450.00
  4. 05 Feb 2021  |  North America  |  Mega Trends

    Shifting Spotlight from Product- to Value-based Outcomes Intensifies Growth in the US Real-world Evidence IT Solutions Market

    Early-stage R&D and Commercial Applications Fuel the Growth Pipeline

    The US healthcare industrys transition to a patient-centric model is moving rapidly with focus on outcomes and value; however, drug prices have increased and pharmaceutical research and development (R&D) productivity is at its lowest. The healthcare industry and IT solutions providers are finding real-world evidence (RWE) as a potential solution to...

    $4,950.00
  5. 03 Feb 2021  |  North America  |  Mega Trends

    Companion Diagnostics (CDx) is Revolutionizing the Global Clinical Next-generation Sequencing (NGS) Market

    Next-generation Blockchain-Powered Genomic Data Marketplaces are Creating New Growth Opportunities

    2020 will be remembered for the COVID-19 pandemic, masks, social distancing protocol, alternate care sites, Moderna, Pfizer, BioNTech, AstraZeneca, RT-PCR, and serology testing (or all the above). However, in the midst of our response to the global pandemic, remarkable advancements were made in another great frontier in medicine that remains unconq...

    $4,950.00
  6. 20 Nov 2012  |  North America  |  Market Research

    The U.S. Health Information Exchange Market

    A Comprehensive Guide to Market Dynamics, Technology Vendors, and Future Trends

    This study provides a roadmap for understanding health information exchange. We provide an in-depth overview of the technical aspects of health information exchange (HIE), review major government initiatives driving health information exchange efforts across the U.S.,  define and describe the major market segments and subsegments, and look at rece...

    $4,950.00
  7. 27 Sep 2012  |  Europe  |  Market Research

    European Alzheimers Disease Medication Market

    Launch of Disease-modifying Drugs expected to Boost Market Growth

    The key objective of this research service  is to study the European Alzheimers disease medication market based on the three major classes of drugs namely acetylcholinesterase inhibitors, NMDA receptor antagonists and new mechanism/ disease modifying drugs and identify the key current and future trends shaping these market segments.  It also aims...

    $4,950.00
  8. 31 Aug 2012  |  Asia Pacific  |  Market Research

    Strategic Analysis of Contract Research and Manufacturing Services Market in India

    Presenting Opportunities for Market Share Gain

    This study provides a comprehensive analysis of the contract research and manufacturing services (CRAMS) segment in India by focusing on drug discovery to pre-clinical toxicology, Active Pharmaceutical Ingredient (API), Formulations and Injectables. The study is based on detailed primary research, and includes an evaluation of the market size as ...

    $4,950.00
  9. 15 May 2012  |  North America  |  Market Research

    Mölnlycke Health Care—Company Profile

    This market insight provides an overview of Mölnlycke Health Care. The Mölnlycke company was established in 1849 by G.F. Henning as primarily a textile manufacturer. In 1997, Mölnlycke Health Care came in to existence when Nordic Capital acquired the medical devices segment of SCA. The company is currently owned by Investor AB and has seen stea...

    $1,500.00
  10. 19 Jan 2012  |  Global  |  Technology Research

    Advances in Pharmacovigilance Techniques--Technology Benchmarking and Stakeholder Analysis (Technical Insights)

    A Drug Safety Toolkit Moving toward Improved Drug Safety Systems

    Pharmacovigilance activities revolve around ensuring drug safety and preventing adverse drug reactions. While post marketing studies form the core of pharmacovigilance, inclusion of safety measures during clinical development and carrying out additional post marketing active surveillance is being utilized by a number of pharma companies.  Risks ...

    $4,950.00